XML 79 R64.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivatives (Schedule Of Derivative Activity For Derivatives Designated As Cash Flow Hedges) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) $ 17,598 $ (11,029)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) (2) (1)
Gain/(Loss) from Amounts Excluded from Effectiveness Testing 554 (3,648)
Gain/(Loss) Recognized in AOCI (Effective Portion) (1,726) 34,450
Foreign Exchange Contracts [Member]
   
Derivative [Line Items]    
Gain/(Loss) Recognized in AOCI (Effective Portion) (1,664) 34,748
Foreign Exchange Contracts [Member] | Cost of Sales [Member]
   
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 17,834 (10,866)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 0 0
Gain/(Loss) from Amounts Excluded from Effectiveness Testing 0 0
Foreign Exchange Contracts [Member] | SG&A [Member]
   
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (63) 0
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 0 0
Gain/(Loss) from Amounts Excluded from Effectiveness Testing 0 0
Foreign Exchange Contracts [Member] | Foreign Exchange Losses, Net [Member]
   
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) 0 0
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) 0 0
Gain/(Loss) from Amounts Excluded from Effectiveness Testing 554 (3,648)
Interest Rate Swap [Member]
   
Derivative [Line Items]    
Gain/(Loss) Recognized in AOCI (Effective Portion) (62) (298)
Interest Rate Swap [Member] | Selling General And Administrative Expense [Member]
   
Derivative [Line Items]    
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion) (173) (163)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion) (2) (1)
Gain/(Loss) from Amounts Excluded from Effectiveness Testing $ 0 $ 0